{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:13:19Z","timestamp":1791825199382,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KQTD20180411185028798"],"award-info":[{"award-number":["KQTD20180411185028798"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Municipal Fundamental Research Program","doi-asserted-by":"publisher","award":["JCYJ20180508153249223"],"award-info":[{"award-number":["JCYJ20180508153249223"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Municipal Fundamental Research Program","doi-asserted-by":"publisher","award":["JCYJ2020109150427184"],"award-info":[{"award-number":["JCYJ2020109150427184"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Cancer Center"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jncc.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T17:47:05Z","timestamp":1732816025000},"page":"38-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Cai-Ning","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Leung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hang Keith","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sik-Kwan Kenneth","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bong James","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Mau","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yan Albert","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming (Spring)","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jncc.2024.06.007_bib0001","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jncc.2024.06.007_bib0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors","volume":"15","author":"Xu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"7798","key":"10.1016\/j.jncc.2024.06.007_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","article-title":"Peripheral T cell expansion predicts tumour infiltration and clinical response","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jncc.2024.06.007_bib0004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jncc.2024.06.007_bib0005","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00262-021-02848-0","article-title":"Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient","volume":"70","author":"Zhong","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.jncc.2024.06.007_bib0006","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-021-21928-4","article-title":"Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy","volume":"12","author":"De Biasi","year":"2021","journal-title":"Nat Commun"},{"issue":"27","key":"10.1016\/j.jncc.2024.06.007_bib0007","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1073\/pnas.1918937117","article-title":"Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy","volume":"117","author":"Griffiths","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jncc.2024.06.007_bib0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy","volume":"24","author":"Krieg","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jncc.2024.06.007_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-020-10014-4","article-title":"Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma","volume":"14","author":"Park","year":"2020","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.jncc.2024.06.007_bib0010","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/cclm-2013-0878","article-title":"Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients","volume":"52","author":"Li","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.jncc.2024.06.007_bib0011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.hbpd.2020.12.015","article-title":"The effects of stereotactic body radiotherapy on peripheral natural killer and CD3+CD56+ NKT-like cells in patients with hepatocellular carcinoma","volume":"20","author":"Li","year":"2021","journal-title":"Hepatob Pancreatic Dis Int"},{"issue":"5","key":"10.1016\/j.jncc.2024.06.007_bib0012","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ijrobp.2018.04.026","article-title":"Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer","volume":"101","author":"Grassberger","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jncc.2024.06.007_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/gutjnl-2017-315485","article-title":"Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma","volume":"68","author":"Chew","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jncc.2024.06.007_bib0014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","article-title":"Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial","volume":"8","author":"Chiang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jncc.2024.06.007_bib0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.jncc.2024.06.007_bib0016","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jfma.2020.11.015","article-title":"The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma","volume":"120","author":"Hung","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jncc.2024.06.007_bib0017","doi-asserted-by":"crossref","first-page":"e96080","DOI":"10.1371\/journal.pone.0096080","article-title":"Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jncc.2024.06.007_bib0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.23291","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells","volume":"51","author":"Kuang","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jncc.2024.06.007_bib0019","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jncc.2024.06.007_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-9966-32-3","article-title":"High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma","volume":"32","author":"Liao","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.jncc.2024.06.007_bib0021","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ijc.23001","article-title":"Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer","volume":"121","author":"Strauss","year":"2007","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.jncc.2024.06.007_bib0022","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jncc.2024.06.007_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/intimm\/dxn120","article-title":"IL-2 receptor gamma chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosis","volume":"21","author":"Crawley","year":"2009","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.jncc.2024.06.007_bib0024","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.174.5.2900","article-title":"Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals","volume":"174","author":"Paiardini","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jncc.2024.06.007_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/JHC.S282062","article-title":"Radiation-associated lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy","volume":"8","author":"De","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"7547","key":"10.1016\/j.jncc.2024.06.007_bib0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.06.007_bib0027","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/aps.2015.41","article-title":"Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy","volume":"36","author":"Sun","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.jncc.2024.06.007_bib0028","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1078-0432.CCR-16-1432","article-title":"Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells","volume":"23","author":"Tang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.06.007_bib0029","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fonc.2019.01157","article-title":"Combined stereotactic body radiotherapy and checkpoint inhibition in unresectable hepatocellular carcinoma: a potential synergistic treatment strategy","volume":"9","author":"Chiang","year":"2019","journal-title":"Front Oncol"}],"container-title":["Journal of the National Cancer Center"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005424001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005424001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:05:18Z","timestamp":1740895518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667005424001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2667005424001030"],"URL":"https:\/\/doi.org\/10.1016\/j.jncc.2024.06.007","relation":{},"ISSN":["2667-0054"],"issn-type":[{"value":"2667-0054","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Cancer Center","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jncc.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Chinese National Cancer Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}